approval
saveTRULICITY (DULAGLUTIDE) — FDA approval
community read0 votes
Sponsor: ELI LILLY AND CO. Form: INJECTABLE. Route: INJECTION
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 8
- approvalTRULICITY (DULAGLUTIDE) — FDA approvalMay 28, 2025 · 494d ago
- approvalTRULICITY (DULAGLUTIDE) — FDA approvalNov 1, 2024 · 702d ago
- approvalTRULICITY (DULAGLUTIDE) — FDA approvalNov 1, 2024 · 702d ago
- approvalTRULICITY (DULAGLUTIDE) — FDA approvalNov 17, 2022 · 1417d ago
- approvalTRULICITY (DULAGLUTIDE) — FDA approvalJun 10, 2022 · 1577d ago
- approvalTRULICITY (DULAGLUTIDE) — FDA approvalJun 10, 2022 · 1577d ago
- approvalTRULICITY (DULAGLUTIDE) — FDA approvalSep 30, 2021 · 1830d ago
- approvalTRULICITY (DULAGLUTIDE) — FDA approvalSep 3, 2020 · 2222d ago
same company · ±60 days · 5
- approvalZEPBOUND: ZEPBOUND (TIRZEPATIDE) — FDA approvalFeb 25, 2026
- approvalorforglipron calcium: FOUNDAYO (ORFORGLIPRON CALCIUM) — FDA approvalApr 1, 2026
- earningsELI LILLY & Co earningsApr 30, 2026
- approvalZEPBOUND: MOUNJARO (TIRZEPATIDE) — FDA approvalJan 20, 2026
- approvalZEPBOUND: ZEPBOUND (TIRZEPATIDE) — FDA approvalJan 20, 2026
comments(0)
5-min edit window · permanent after that